Currently, the coexistence of glucose and lipid metabolism disorders, as well as arterial hypertension, which constitute criteria of metabolic syndrome (MetS), are more and more frequently observed, and concern mainly obese and insulin-resistant individuals (Reaven, 1988; McCracken et al., 2018). This evidence concerns the gene INS and metabolic syndrome.